Science12 hours ago
Assembly Biosciences Price Target Increased to $39 by Guggenheim
Assembly Biosciences (NASDAQ: ASMB) received a significant boost as Guggenheim raised its price target for the biopharmaceutical company’s stock from $31.00 to $39.00. This adjustment, reported...